BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8312423)

  • 1. Oxalate removal in type I hyperoxaluria or acquired oxalosis using HD and equilibration PD.
    Bunchman TE; Swartz RD
    Perit Dial Int; 1994; 14(1):81-4. PubMed ID: 8312423
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria.
    Tang X; Voskoboev NV; Wannarka SL; Olson JB; Milliner DS; Lieske JC
    Am J Nephrol; 2014; 39(5):376-82. PubMed ID: 24776840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxalate removal by daily dialysis in a patient with primary hyperoxaluria type 1.
    Yamauchi T; Quillard M; Takahashi S; Nguyen-Khoa M
    Nephrol Dial Transplant; 2001 Dec; 16(12):2407-11. PubMed ID: 11733634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1.
    Illies F; Bonzel KE; Wingen AM; Latta K; Hoyer PF
    Kidney Int; 2006 Nov; 70(9):1642-8. PubMed ID: 16955107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria.
    Plumb TJ; Swee ML; Fillaus JA
    Am J Kidney Dis; 2013 Dec; 62(6):1155-9. PubMed ID: 23830800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long daily hemodialysis sessions correct systemic complications of oxalosis prior to combined liver-kidney transplantation: case report.
    Díaz C; Catalinas FG; de Alvaro F; Torre A; Sánchez C; Costero O
    Ther Apher Dial; 2004 Feb; 8(1):52-5. PubMed ID: 15128020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis.
    Hoppe B; Dittlich K; Fehrenbach H; Plum G; Beck BB
    Am J Kidney Dis; 2011 Sep; 58(3):453-5. PubMed ID: 21705122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of assessment of serum calcium oxalate saturation in the hyperoxaluria syndromes.
    Marangella M; Vitale C; Petrarulo M; Linari F
    Nephrol Dial Transplant; 1995; 10 Suppl 8():11-3. PubMed ID: 8592617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria.
    Marangella M; Petrarulo M; Cosseddu D; Vitale C; Linari F
    Am J Kidney Dis; 1992 Jun; 19(6):546-53. PubMed ID: 1595703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure.
    Watts RW; Veall N; Purkiss P
    Clin Sci (Lond); 1984 May; 66(5):591-7. PubMed ID: 6368103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004.
    Jamieson NV;
    Am J Nephrol; 2005; 25(3):282-9. PubMed ID: 15961948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.
    Hoppe B; Groothoff JW; Hulton SA; Cochat P; Niaudet P; Kemper MJ; Deschênes G; Unwin R; Milliner D
    Nephrol Dial Transplant; 2011 Nov; 26(11):3609-15. PubMed ID: 21460356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hereditary hyperoxaluria or oxalosis. Apropos of a case].
    Bayoudh F; Landthaler G; Hue G; Hecketsweiler B; Mallet E
    Ann Pediatr (Paris); 1989 May; 36(5):321-5. PubMed ID: 2742316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystalline retinopathy in primary hyperoxaluria.
    Punjabi OS; Riaz K; Mets MB
    J AAPOS; 2011 Apr; 15(2):214-6. PubMed ID: 21596303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and urine measurements for monitoring of treatment in the primary hyperoxaluric patient.
    Kasidas GP
    Nephrol Dial Transplant; 1995; 10 Suppl 8():8-10. PubMed ID: 8592630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of late-onset primary hyperoxaluria type 1.
    Blaschke S; Grupp C; Haase J; Kleinoeder T; Hallermann C; Troche I; Gröne HJ; Müller GA
    Am J Kidney Dis; 2002 Feb; 39(2):E11. PubMed ID: 11840402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival on renal replacement therapy for primary hyperoxaluria type I.
    Calzavara P; Marangella M; Petrarulo M; Ballanti P; Bonucci E; Calconi G; Maresca MC; da Porto A; Vianello A
    Nephron; 1993; 63(2):217-21. PubMed ID: 8450916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria.
    Elgstoen KB; Johnsen LF; Woldseth B; Morkrid L; Hartmann A
    Nephrol Dial Transplant; 2010 Jul; 25(7):2341-5. PubMed ID: 20167571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal transplantation in primary hyperoxaluria/oxalosis: a report of two cases.
    Paul MD; Parfrey PS; Harnett JD; Arbus G; Cohen A; Dancey J; Gault MH
    Transplant Proc; 1987 Aug; 19(4):3431-2. PubMed ID: 3303511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.